Congenital adrenal hyperplasia with polycystic ovarian disease: A rare cause of hirsutism
DOI:
https://doi.org/10.66344/jpad.v20i3.414Keywords:
Hirsutism, non-classical congenital adrenal hyperplasia, polycystic ovarian diseaseAbstract
Hirsutism may be defined as presence of terminal hairs in women with a male-like pattern of distribution. Hirsutism is related to serum androgen and cutaneous sensitivity to other hormones. The most prevalent causes of hirsutism are polycystic ovary syndrome and isolated hirsutism. Non-classical congenital adrenal hyperplasia (21-hydroxylase deficiency) and drug induced type are less frequent rather rare causes. Diagnostic evaluations should address identifying etiology and its associated co-morbidities to properly manage the patients. We present a case of 22-year-old unmarried female who presented with hirsutism and on detailed evaluation she was diagnosed as a case of nonclassical adrenal hyperplasia and polycystic ovaries. Along with laser hair removal, proper treatment of underlying etiology led to reversal of her symptoms.
References
1. Somani N, Harrison S, Bregfeld WF. The Clinical evaluation of hirsutism. Dermatol Ther 2008; 21: 376-91.
2. Ahmad QM, Shah IH, Sameen F et al. Hirsutism in Kashmir: an etiological study. Indian J Dermatol 2009; 54: 80-2.
3. Spritzer PM. Etiological diagnosis of hirsutism and implications for treatment. Rev Bras Gynecol Obstet 2009; 31: 41-7.
4. Blume-Peytavi U, Hahn S. Medical treatment of hirsutism. Dermatol Ther 2008; 21: 329-39.
5. Mustafa R, Hashmi AH, Ullah S. Congenital adrenal hyperplasia causing clitoromegaly. J Coll Physicians Surg Pak 2008; 18: 378-9.
6. Trakakis E, Loghis C, Kassanos D. Congenital adrenal hyperplasia because of 21-hydroxylase deficiency. A genetic disorder of interest to obstetricians & gynecologist. Obstet Gynecol Surg 2009; 64:177-89.
7. Trakakis E, Rizos D, Loghis C et al. The prevalence of nonclassical congenital adrenal hyperplasia due to 21 hydroxylase deficiency in Greek woman with hirsutism and polycystic ovary syndrome. Endocrinol J 2008; 55: 33-9.
8. Singh RJ. Quantization of 17-OH progesterone for diagnosis of congenital adrenal hyperplasia (CAH). Methods Mol Biol 2010; 603: 271-7.
9. Glintborg D, Andersen M. An update on pathogenesis, inflammation and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol 2010; 26: 281-96.
10. Alexander CJ, Tangchitnob EP, Lepor NE. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. Rev Obstet Gynecol 2009; 2: 232-9.
11. Dewailly D, Hieronimus S, Mirakian P, Hugues JN. Polycystic ovary syndrome (PCOS) Ann Endocrinol 2010; 71: 8-13.
12. Lin-Su K, Nimkarin S, New MI. Congenital adrenal hyperplasia in adolescents, diagnosis and management. Ann N Y Acad Sci 2008; 1135: 95-8.
13. New MI. Extensive clinical experience: non classical 21 hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91; 4205-14
14. Fanta M, Cibula D, Vrbikova J. Prevalence of non classical adrenal hyperplasia (NC-CAH) in hyperandrogenic woman. Gynecol Endrocrinol 2008; 24: 154-7
15. Bidet M, Bellanne-Chantelot C, Gland-Portier MB et al. Fertility in the woman with non classical congenital adrenal hyperplasia due to 21 hydroxylase deficiency. J Clin Endocrinol Metab 2010; 95:1182-90.
16. Falhmmar H, Thoren M, Hagenfeldt K. A 31-year-old woman with infertility and polycystic ovaries diagnosed with non classical congenital adrenal hyperplasia due to novel CYP21 mutation. J Endocrinol Invest 2008; 31: 176-80.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Shazia Rasul, Lubna Riaz Dar, Abdul Hameed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
